Clinical Trial

Massive Bio, a leader in AI-powered cancer treatment, announced plans to launch a new AI-powered drug matching product in 2023 that will enable…

Massive Bio, a leader in AI-powered cancer clinical trial enrollment, announced a strategic partnership with Perthera.ai, a pioneer in connecting…

Transgene , a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB, a biotech…

Aifred Health, an award-winning digital healthcare company, announced the treatment of the first patient in its 350 patient North American Clinical…

ProofPilot, a leading Software as a Service (SaaS) clinical trial research platform, today announced its first ever Open Invitation for Research, in…

– Randomized Phase 3 Clinical Trial of ADCETRIS Combination Met Key Secondary OS Endpoint, Demonstrating a 41% Reduction in Risk of Death vs.…

FDA review of manufacturing plans and pharmacy procedures associated with a recently placed clinical hold on the FLAMINGO-01 phase III clinical…

Recently completed clinical trial provides third party validation of the accuracy of Olive's continuous monitoring technology over traditional urine…

On December 23, Regor Therapeutics, a clinical-stage biotech company, announced authorization from the US Food and Drug Administration (FDA) to…

Aopeng Medical's ALLVAS Endovascular Intervention Surgical Robot, successfully completed the first-in-human clinical evaluation of robot-assisted…